Susquehanna International Group
SBBP

Susquehanna International Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Susquehanna International Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,200
Closed -$23K – 14508
2021
Q3 		$23K Sell
11,200
-4,700
-30% -$10.9K ﹤0.01% 12527
2021
Q2 		$47K Sell
15,900
-1,600
-9% -$4.22K ﹤0.01% 12321
2021
Q1 		$48K Buy
+17,500
New +$52.8K ﹤0.01% 12045
2020
Q3 		– Sell
-10,300
Closed -$39K – 11423
2020
Q2 		$39K Buy
+10,300
New +$30.9K ﹤0.01% 9816

Susquehanna International Group's SBBP Position: Q4 2021 in Review

Susquehanna International Group sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 155,457 shares — an estimated $317K sold.

Susquehanna International Group first reported a position in SBBP in Q2 2018 and held it in 10 quarters. The position peaked at $498K in Q2 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Susquehanna International Group reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Susquehanna International Group sold 155,457 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $317K.
  • Susquehanna International Group first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 10 quarters.
  • Susquehanna International Group's Strongbridge Biopharma plc. position peaked at $498K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.